IL2 and neoplasm: Furthermore, the selection of tumor-reactive T cells based on the high expression of co-stimulatory molecules such as 4-1BB or OX-40 may contribute to a ‘fit’ T cell product, as it is expected that these cells are less prone to lose antitumor effector functions during expansion in IL-2 culture conditions [58].